Suppr超能文献

小极性人参皂苷 Rg2 和 Rh1 通过下调 TLR4-STAT1 的激活和巨噬细胞中炎症细胞因子的产生来减轻 LPS 诱导的急性肝和肾损伤。

Minor Ginsenoside Rg2 and Rh1 Attenuates LPS-Induced Acute Liver and Kidney Damages via Downregulating Activation of TLR4-STAT1 and Inflammatory Cytokine Production in Macrophages.

机构信息

College of Pharmacy and Institute of Drug Research and Development, Chungnam National University, Daejeon 34134, Korea.

Department of Chemicals Assessment, Korea Environment Corporation, Incheon 404-708, Korea.

出版信息

Int J Mol Sci. 2020 Sep 11;21(18):6656. doi: 10.3390/ijms21186656.

Abstract

Ginsenosides have been reported to have various biological effects, such as immune regulation and anticancer activity. In this study, we investigated the anti-inflammatory role of a combination of Rg2 and Rh1, which are minor ginsenosides, in lipopolysaccharide (LPS)-stimulated inflammation. In vitro experiments were performed using the RAW264.7 cell line, and an in vivo model of inflammation was established using LPS-treated ICR mice. We employed Griess assay, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, quantitative reverse transcriptase-polymerase chain reaction, western blotting, immunofluorescence staining, and hematoxylin and eosin staining to evaluate the effect of Rg2 and Rh1. We found that Rg2 and Rh1 significantly decreased LPS-induced major inflammatory mediator production, inducible-nitric oxide synthase expression, and nitric oxide production in macrophages. Moreover, Rg2 and Rh1 combination treatment inhibited the binding of LPS to toll-like receptor 4 (TLR4) on peritoneal macrophages. Therefore, the combination of ginsenoside Rg2 and Rh1 suppressed inflammation by abolishing the binding of LPS to TLR4, thereby inhibiting the TLR4-mediated signaling pathway. The combined ginsenoside synergistically blocked LPS-mediated PKCδ translocation to the plasma membrane, resulting in p38-STAT1 activation and NF-κB translocation. In addition, mRNA levels of pro-inflammatory cytokines, including TNF-α, IL-1β, and IFN-β, were significantly decreased by combined ginsenoside treatment. Notably, the 20 mg/kg ginsenoside treatment significantly reduced LPS-induced acute tissue inflammation levels in vivo, as indicated by the tissue histological damage scores and the levels of biochemical markers for liver and kidney function from mouse serum. These results suggest that the minor ginsenosides Rg2 and Rh1 may play a key role in prevention of LPS-induced acute inflammation and tissue damage.

摘要

人参皂苷已被报道具有多种生物效应,如免疫调节和抗癌活性。在这项研究中,我们研究了 Rg2 和 Rh1(两种次要人参皂苷)联合应用在脂多糖(LPS)刺激的炎症中的抗炎作用。采用 RAW264.7 细胞系进行体外实验,采用 LPS 处理的 ICR 小鼠建立体内炎症模型。我们采用格里塞斯测定法、3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐(MTT)测定法、定量逆转录聚合酶链反应、western blot、免疫荧光染色和苏木精和伊红染色来评估 Rg2 和 Rh1 的作用。我们发现 Rg2 和 Rh1 可显著降低 LPS 诱导的巨噬细胞中主要炎症介质产生、诱导型一氧化氮合酶表达和一氧化氮产生。此外,Rg2 和 Rh1 联合治疗抑制了 LPS 与腹腔巨噬细胞上的 toll 样受体 4(TLR4)的结合。因此,人参皂苷 Rg2 和 Rh1 的联合应用通过消除 LPS 与 TLR4 的结合来抑制 TLR4 介导的信号通路,从而抑制炎症。该联合人参皂苷协同阻断 LPS 介导的蛋白激酶 Cδ(PKCδ)向质膜易位,导致 p38-STAT1 激活和 NF-κB 易位。此外,联合用人参皂苷处理可显著降低 TNF-α、IL-1β 和 IFN-β 等促炎细胞因子的 mRNA 水平。值得注意的是,20 mg/kg 的人参皂苷治疗可显著降低 LPS 诱导的体内急性组织炎症水平,这可从组织组织学损伤评分和小鼠血清中肝肾功能生化标志物的水平来判断。这些结果表明,次要人参皂苷 Rg2 和 Rh1 可能在预防 LPS 诱导的急性炎症和组织损伤中发挥关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3aa5/7555743/dfebcb12a467/ijms-21-06656-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验